SAPERSTEIN ANDREW M

Morgan Stanley Co-President Saperstein sells 51,668 shares for $9,744,322.10 across 6 transactions on 2026-04-16

Andrew M Saperstein, Co-President of Morgan Stanley, executed 6 separate sales totaling 51,668 shares (51.7K shares) for $9,744,322.10 on 2026-04-16 at prices ranging from $187.20 to $192.12, representing a -15.5% reduction in his holdings from 333,810 to 282,142 shares. The sale occurred near the stock's 52-week high of $191.62 (current price $188.82 is -1.5% from that peak), and the blended average price of $188.59 exceeds the current price. Saperstein's prior 5 same-ticker sales at Morgan Stanley (all on 2026-01-20) showed negative 30-day returns averaging -5.4%, and his cross-ticker track record of 16 prior sells displays a 40.00% well-timed rate with average 90-day returns of -0.6%, indicating mixed historical accuracy in timing exits. This large concentrated sale merits observation as a material reduction of an insider's stake, though the execution at price levels close to recent resistance suggests opportunistic selling rather than forced liquidation.

Co-President SAPERSTEIN sells 30,330 shares for $5,569,085.93 at avg price $183.62

SAPERSTEIN ANDREW M, Co-President of Morgan Stanley, executed 6 separate sales on 2026-01-20 totaling 30,330 shares for $5,569,085.93, reducing his holdings by 9.8% to 280,480 shares. The blended average price of $183.62 sits near the current price of $183.05, which is 4.3% below the 52-week high of $191.23. His prior transactions at Morgan Stanley show mixed outcomes: 3 of 5 recent sells had positive 90-day returns (including +15.1%, +15.6%, and +18.7%), while 2 resulted in declines (−22.4%, −21.9%), indicating inconsistent timing performance at this ticker. Cross-ticker, his broader track record shows a 40% well-timed sell rate, suggesting his transactions are not systematically prescient. Morgan Stanley's fundamentals remain solid with $18.2B revenue, $4.6B net income, and 14.1% annual growth, though the P/E of 17.98 and the stock's recent 11.7% 90-day gain provide limited margin of safety context for this near-peak-price transaction.

Morgan Stanley Co-President Andrew Saperstein sells entire 43.6K share position for $6.1M at $140.97 average, exiting stake completely

Andrew Saperstein executed 2 separate sales totaling 43,566 shares for $6,141,714.20 on 2025-07-17, eliminating his entire MS holding (100% reduction from pre-transaction position). The blended average price of $140.97 is within 0.2% of the current price of $140.83, suggesting near-term execution at fair value relative to the market. Saperstein's prior trades at MS show a 75% well-timed rate at the 90-day mark (3 of 4 measurable prior MS sales experienced negative subsequent 90-day returns), though his cross-ticker track record demonstrates a 57.14% well-timed rate on sells, slightly above 50%. The complete exit of a large position by an executive officer merits investor attention, particularly given MS's strong recent momentum (+29.0% over 90 days, +6.3% over 30 days) and solid fundamentals (P/E 15.81, +14.1% annual revenue growth, $4.3B net income on $17.7B quarterly revenue).

Morgan Stanley Co-President SAPERSTEIN sold 40,000 shares at $120.00 for $4.8M on 2025-05-02

SAPERSTEIN ANDREW M, Co-President of Morgan Stanley, sold 40,000 shares (10.6% of his pre-transaction holdings) at $120.00 on 2025-05-02, reducing his position from 375.8K to 335.8K shares. The current price is $120.22, only 0.8% higher on a 30-day basis, though the stock has declined 13.2% over 90 days and trades 14.8% below its 52-week high of $141.08. His cross-ticker track record shows 7 prior open-market sells with a 90-day well-timed rate of 57.14%, while at Morgan Stanley specifically, he has 5 prior documented sells with 3 of 5 showing negative 90-day returns. Against Morgan Stanley's strong fundamentals (revenue of $15.4B, net income of $3.2B, P/E of 12.51, annual revenue growth of +14.1%), this single sale does not appear to signal a material shift in the Co-President's overall conviction; rather, it represents an incremental portfolio adjustment by an executive who retains 335.8K shares after the transaction.

Morgan Stanley Co-President Andrew Saperstein sold 30.8K shares for $4.2M near 52-week high; post-sale holds 327.0K shares

Andrew Saperstein executed 3 separate sales totaling 30,820 shares for $4,204,675.68 at a blended average price of $136.43, occurring as Morgan Stanley trades near its 52-week high of $137.87 (current price $137.80, -0.0% from peak). This 8.6% reduction in his holdings comes after the stock gained 8.4% over 30 days and 17.9% over 90 days. His prior 4 sales at Morgan Stanley show mixed timing outcomes: one trade preceded a 90-day decline, while three were followed by gains (25% well-timed rate at the 90-day mark across his entire cross-ticker history). The sale occurs against a backdrop of moderate fundamentals—Morgan Stanley posted 15.4B in latest quarterly revenue with 0.9% annual growth and trades at a 19.83 P/E ratio.